CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Stock Option (Right to Buy) | −66,163 | 0 | ||
| 2023-04-28 | Davis Robert M Chairman, CEO & President | Option exercise | +143,329 | $56.04 | $8.0M | 415,145.76 |
| 2023-04-28 | Davis Robert M Chairman, CEO & President | Sale | −143,329 | $114.93 | $16.5M | 271,816.76 |
| 2023-04-28 | Davis Robert M Chairman, CEO & President | Option exercise · Stock Option (Right to Buy) | −143,329 | 0 | ||
| 2023-04-26 | Romanelli Joseph President, Human Health Int?l | Purchase | +3 | $113.68 | $341 | 20,599.33 |
| 2023-04-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise | +67,892 | $56.04 | $3.8M | 67,892 |
| 2023-04-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise | +66,163 | $62.07 | $4.1M | 134,055 |
| 2023-04-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −66,163 | $115.06 | $7.6M | 67,892 |
| 2023-04-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −67,892 | $115.07 | $7.8M | 0 |
| 2023-04-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise · Stock Option (Right to Buy) | −67,892 | 0 | ||
| 2023-04-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise · Stock Option (Right to Buy) | −66,163 | 0 | ||
| 2023-03-31 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +304.17 | $106.39 | $32K | 17,499.15 |
| 2023-03-31 | WENDELL PETER C Director | Grant or award · Phantom Stock | +281.98 | $106.39 | $30K | 118,477.84 |
| 2023-03-31 | Seidman Christine E Director | Grant or award · Phantom Stock | +76.37 | $106.39 | $8K | 10,339.61 |
| 2023-03-31 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +422.97 | $106.39 | $45K | 87,408.85 |
| 2023-03-24 | Romanelli Joseph President, Human Health Int?l | Sale | −35 | $104.65 | $4K | 20,596.33 |
| 2023-03-20 | Romanelli Joseph President, Human Health Int?l | Purchase | +136 | $105.47 | $14K | 20,631.33 |
| 2023-02-21 | Romanelli Joseph President, Human Health Int?l | Purchase | +11 | $109.20 | $1K | 20,495.33 |
| 2023-02-15 | Romanelli Joseph President, Human Health Int?l | Sale | −5,000 | $108.22 | $541K | 20,284.33 |
| 2023-02-13 | MIZELL STEVEN EVP, Chief HR Officer | Sale | −1,815 | $109.10 | $198K | 33,085.15 |
Page 26 of 29 · 572 trades